Cas:98827-44-2 Methyl 4-hydroxy-2H-thieno[2,3-e][1,2]thiazine-3-carboxylate 1,1-dioxide manufacturer & supplier

We serve Chemical Name:Methyl 4-hydroxy-2H-thieno[2,3-e][1,2]thiazine-3-carboxylate 1,1-dioxide CAS:98827-44-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Methyl 4-hydroxy-2H-thieno[2,3-e][1,2]thiazine-3-carboxylate 1,1-dioxide

Chemical Name:Methyl 4-hydroxy-2H-thieno[2,3-e][1,2]thiazine-3-carboxylate 1,1-dioxide
CAS.NO:98827-44-2
Synonyms:methyl 4-hydroxy-1,1-dioxo-2H-thieno[2,3-e]thiazine-3-carboxylate
Molecular Formula:C8H7NO5S2
Molecular Weight:261.27500
HS Code:2934991000

Physical and Chemical Properties:
Melting point:N/A
Boiling point:464.2ºC at 760 mmHg
Density:1.716g/cm3
Index of Refraction:1.667
PSA:129.32000
Exact Mass:260.97700
LogP:1.84920

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like methyl 4-hydroxy-1,1-dioxo-2H-thieno[2,3-e]thiazine-3-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methyl 4-hydroxy-1,1-dioxo-2H-thieno[2,3-e]thiazine-3-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl 4-hydroxy-1,1-dioxo-2H-thieno[2,3-e]thiazine-3-carboxylate Use and application,methyl 4-hydroxy-1,1-dioxo-2H-thieno[2,3-e]thiazine-3-carboxylate technical grade,usp/ep/jp grade.


Related News: This announcement follows earlier expansions at the Ballina site where additional Good Manufacturing Practice (GMP) facilities and capabilities have been added in analytical, cell culture, vaccine support and other specialised Biologics services. 3-benzhydryl-1-[2-[bis(2-chloroethyl)amino]-2-oxo-1,3,2λ(sup)5(/sup)-oxazaphosphinan-4-yl]-1-hydroxyurea manufacturers About eight months after originally teaming up on neuromuscular diseases, Takeda and PeptiDream have expanded the pact to include several central nervous system targets, while revealing the tie-up could be worth more than $3.5 billion. A name could not be generated for this structure. suppliers Ultimately, AZ hopes to shape the market by working with Chinese authorities to develop guidance on how rare disease drugs can be included for national coverage at reasonable prices, Wang said. 2-methyl-N-(2-(2-pentylcyclopropyl)thiophen-3-yl)-4-(trifluoromethyl)thiazole-5-carboxamide vendor & factory.